Cargando…
Immunoreactive Trypsinogen and Free Carnitine Changes on Newborn Screening after Birth in Patients Who Develop Type 1 Diabetes
Are free carnitine concentrations on newborn screening (NBS) 48–72 h after birth lower in patients who develop type 1 diabetes than in controls? A retrospective case-control study of patients with type 1 diabetes was conducted. NBS results of patients from a Sydney hospital were compared against mat...
Autores principales: | Estrella, Jane Frances Grace Lustre, Wiley, Veronica C., Simmons, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538382/ https://www.ncbi.nlm.nih.gov/pubmed/34684667 http://dx.doi.org/10.3390/nu13103669 |
Ejemplares similares
-
Newborn Screening Samples for Diabetes Research: An Underused Resource
por: Estrella, Jane Frances Grace Lustre, et al.
Publicado: (2020) -
Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019) -
False-negative newborn screening result for immunoreactive trypsinogen: a major problem in children with chronic lung disease
por: Lumertz, Magali Santos, et al.
Publicado: (2019) -
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors
por: Kharrazi, Martin, et al.
Publicado: (2022) -
Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor
por: Patel, Payal, et al.
Publicado: (2023)